Drugs / TILs injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07498439 | Mar 2026 → Mar 2028 expected | non-small cell lung carcinoma | Tianjin Medical University General Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TILs injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07498439 ↗ |
| Modality | Cell therapy | “isolate immune cells, and prepare TILs Infusion” NCT07498439 ↗ |
| Route | Intravenous | “Administration route: Intravenous Infusion” NCT07498439 ↗ |